Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000518818 | SCV000612599 | benign | not specified | 2017-07-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000865156 | SCV001006082 | benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003419890 | SCV004125279 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CACNA1S: BP4, BP7 |
Genome- |
RCV003449469 | SCV004177877 | benign | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449470 | SCV004177878 | benign | Thyrotoxic periodic paralysis, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458446 | SCV004177879 | benign | Congenital myopathy 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449468 | SCV004177882 | benign | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |